Synopsys to Cut Fab Control Software, Doubling Down on AI Design

What happened

Synopsys plans to stop offering manufacturing process control software to semiconductor fabs, according to six sources, reallocating resources to higher-margin AI design tools. This move aligns with the company's post-Ansys strategy to focus on integrated silicon-to-systems workflows and AI-driven EDA. The decision comes as Synopsys navigates heavy integration costs—$394M quarterly amortization and a $300M-$350M restructuring plan—that have crushed GAAP operating income. Cutting a legacy product line suggests management is willing to prune lower-margin businesses to improve profitability, potentially accelerating margin recovery. However, the revenue contribution from this product suite is undisclosed, and the shift may also reflect competitive pressure or regulatory constraints around the Ansys merger.

Implication

Investors should view this as a positive step toward Synopsys's focus on higher-margin AI design and simulation software, which could accelerate the margin normalization timeline. The product discontinuation signals management's commitment to portfolio optimization, likely influenced by activist pressure from Elliott. However, the near-term financial impact is ambiguous—the manufacturing control business may be small, but any revenue loss could offset margin gains. The critical test remains whether Synopsys can sustain RPO growth above $43B and show sequential GAAP operating income improvement, as failing to do so would indicate that the AI pivot is not compensating for the loss of legacy revenue. We maintain a WAIT rating until the next earnings print confirms that demand trends remain intact and that the restructuring is on track to deliver measurable margin expansion.

Thesis delta

This news reinforces the bull case that Synopsys is actively reallocating resources toward higher-margin AI and simulation businesses, potentially accelerating profitability improvements. It adds evidence that management is serious about margin enhancement under activist pressure, increasing the probability of the bull scenario earlier than expected. However, the lack of transparency on the revenue contribution of the discontinued business means the net financial impact remains uncertain, and we need to see if this move is a one-off or part of a broader portfolio reshaping.